| Bill | HR 7839 |
|---|---|
| Type of Legislation | House Bill |
| Congress | 116 |
| Status | Archived — 116th Congress concluded |
| Source | View original on Congress.gov |
Geographic Scope
National
Description
Continuing Access to In-Home IVIG Act
This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.
Bill Title
Continuing Access to In-Home IVIG Act
Linked Goals
Steps
- 2020-07-29: Referred to the Subcommittee on Health.
- 2020-07-29: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2020-07-29: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2020-07-29: Introduced in House
- 2020-07-29: Introduced in House
Projected Outcome
A more informed proposal or public response aligned with the Promote General Welfare goal.